Browse by author
Lookup NU author(s): Professor Nick ReynoldsORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2021 The AuthorsA stratified medicine approach for the treatment of psoriasis promises greater certainty of clinical decision making through prediction of response on the basis of clinical, pharmacological, and -omics data from an individual patient. As yet, there is no predictive model for treatment response in routine clinical use for psoriasis. The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium is a United Kingdom Medical Research Council‒funded, academic‒industrial stratified medicine consortium established with the objective of discovering the predictors and stratifiers of response of psoriasis to biologic therapies. A showcase meeting was convened and attended by 80 stakeholders at the Royal College of Physicians, London, United Kingdom on 18 November 2019. The purpose was to disseminate the research findings from the PSORT consortium discovered thus far. This report summarizes the presentations made on the day and the significant advances made by PSORT toward a stratified medicine approach to the management of psoriasis.
Author(s): Yiu ZZN, Barker JNWN, Barnes MR, Di Meglio P, Emsley R, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM
Publication type: Note
Publication status: Published
Journal: Journal of Investigative Dermatology
Year: 2021
Volume: 141
Issue: 8
Pages: 1872-1878
Print publication date: 01/08/2021
Online publication date: 24/03/2021
Acceptance date: 01/02/2021
ISSN (print): 0022-202X
ISSN (electronic): 1523-1747
Publisher: Elsevier B.V.
URL: https://doi.org/10.1016/j.jid.2021.02.746
DOI: 10.1016/j.jid.2021.02.746
PubMed id: 33771529
